Objectives The ideal goal of treatment for juvenile idiopathic arthritis (JIA) is disease remission.
However, many sets of remission criteria have been developed and no systematic review …

The aims of treating juvenile idiopathic arthritis are to elicit treatment response toward
remission, while preventing future flares. Understanding patient and disease characteristics that …

Objectives Many criteria for clinically inactive disease (CID) and minimal disease activity (MDA)
have been proposed for juvenile idiopathic arthritis (JIA). It is not known to what degree …

Background Juvenile idiopathic arthritis (JIA) is a heterogeneous disease, the signs and
symptoms of which can be summarised with use of composite disease activity measures, …

Objectives To quantify and explore risk factors in dogs seen at primary care UK veterinary
clinics for general anaesthetic (GA)/sedative-related death overall, in addition to neuter-…

Objective Potential targets for treat‐to‐target strategies in juvenile idiopathic arthritis are
minimal disease activity ( MDA ) and clinically inactive disease ( CID ). We undertook this study …

Objectives Juvenile PsA (JPsA) has varied clinical features that are distinctive from other JIA
categories. This study investigates whether such features impact patient-reported and …

Objective The goal was to assess the degree of overlap between existing International
League of Associations for Rheumatology (ILAR) and preliminary Paediatric Rheumatology …

Background Methotrexate (MTX) is the gold-standard first-line disease-modifying anti-rheumatic
drug for juvenile idiopathic arthritis (JIA), despite only being either effective or tolerated …

Novel machine learning methods open the door to advances in rheumatology through
application to complex, high-dimensional data, otherwise difficult to analyse. Results from such …